Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
123 4 PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R, R, Rand Rare as defined herein.
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Schumacher, Richard A Hopper, Allen T Tehim, Ashok Hess, Hans-Jurgen Ernst Unterbeck, Axel Kuester, Erik Brubaker, Jr, William Frederick Dunn, Robert F |
| description | 123 4 PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R, R, Rand Rare as defined herein. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07405230</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07405230</sourcerecordid><originalsourceid>FETCH-uspatents_grants_074052303</originalsourceid><addsrcrecordid>eNqNyjEKAjEQheFtLES9Qw7gQnBXPMCiWImFjZXMmjEZiJOQmRTe3hU9gNX383jz5noOSXJIjlAUCwia3hAHGklTkfXU91gdsTenVuooSloVnQGmSIyTzjjKAfkV4fldICYvy2b2gCi4-rlozGF_GY5tlQyKrHLzBT7YXW-3m852f1ze5LE8FA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs</title><source>USPTO Issued Patents</source><creator>Schumacher, Richard A ; Hopper, Allen T ; Tehim, Ashok ; Hess, Hans-Jurgen Ernst ; Unterbeck, Axel ; Kuester, Erik ; Brubaker, Jr, William Frederick ; Dunn, Robert F</creator><creatorcontrib>Schumacher, Richard A ; Hopper, Allen T ; Tehim, Ashok ; Hess, Hans-Jurgen Ernst ; Unterbeck, Axel ; Kuester, Erik ; Brubaker, Jr, William Frederick ; Dunn, Robert F ; Memory Pharmaceuticals Corporation</creatorcontrib><description>123 4 PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R, R, Rand Rare as defined herein.</description><language>eng</language><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7405230$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7405230$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Schumacher, Richard A</creatorcontrib><creatorcontrib>Hopper, Allen T</creatorcontrib><creatorcontrib>Tehim, Ashok</creatorcontrib><creatorcontrib>Hess, Hans-Jurgen Ernst</creatorcontrib><creatorcontrib>Unterbeck, Axel</creatorcontrib><creatorcontrib>Kuester, Erik</creatorcontrib><creatorcontrib>Brubaker, Jr, William Frederick</creatorcontrib><creatorcontrib>Dunn, Robert F</creatorcontrib><creatorcontrib>Memory Pharmaceuticals Corporation</creatorcontrib><title>Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs</title><description>123 4 PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R, R, Rand Rare as defined herein.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNyjEKAjEQheFtLES9Qw7gQnBXPMCiWImFjZXMmjEZiJOQmRTe3hU9gNX383jz5noOSXJIjlAUCwia3hAHGklTkfXU91gdsTenVuooSloVnQGmSIyTzjjKAfkV4fldICYvy2b2gCi4-rlozGF_GY5tlQyKrHLzBT7YXW-3m852f1ze5LE8FA</recordid><startdate>20080729</startdate><enddate>20080729</enddate><creator>Schumacher, Richard A</creator><creator>Hopper, Allen T</creator><creator>Tehim, Ashok</creator><creator>Hess, Hans-Jurgen Ernst</creator><creator>Unterbeck, Axel</creator><creator>Kuester, Erik</creator><creator>Brubaker, Jr, William Frederick</creator><creator>Dunn, Robert F</creator><scope>EFH</scope></search><sort><creationdate>20080729</creationdate><title>Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs</title><author>Schumacher, Richard A ; Hopper, Allen T ; Tehim, Ashok ; Hess, Hans-Jurgen Ernst ; Unterbeck, Axel ; Kuester, Erik ; Brubaker, Jr, William Frederick ; Dunn, Robert F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_074052303</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Schumacher, Richard A</creatorcontrib><creatorcontrib>Hopper, Allen T</creatorcontrib><creatorcontrib>Tehim, Ashok</creatorcontrib><creatorcontrib>Hess, Hans-Jurgen Ernst</creatorcontrib><creatorcontrib>Unterbeck, Axel</creatorcontrib><creatorcontrib>Kuester, Erik</creatorcontrib><creatorcontrib>Brubaker, Jr, William Frederick</creatorcontrib><creatorcontrib>Dunn, Robert F</creatorcontrib><creatorcontrib>Memory Pharmaceuticals Corporation</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Schumacher, Richard A</au><au>Hopper, Allen T</au><au>Tehim, Ashok</au><au>Hess, Hans-Jurgen Ernst</au><au>Unterbeck, Axel</au><au>Kuester, Erik</au><au>Brubaker, Jr, William Frederick</au><au>Dunn, Robert F</au><aucorp>Memory Pharmaceuticals Corporation</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs</title><date>2008-07-29</date><risdate>2008</risdate><abstract>123 4 PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R, R, Rand Rare as defined herein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_07405230 |
| source | USPTO Issued Patents |
| title | Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T21%3A29%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Schumacher,%20Richard%20A&rft.aucorp=Memory%20Pharmaceuticals%20Corporation&rft.date=2008-07-29&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07405230%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |